Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications

被引:759
作者
Berger, J
Reist, M
Mayer, JM
Felt, O
Gurny, R
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Lausanne, Sch Pharm, Lausanne, Switzerland
关键词
biomedical applications; chitosan; complexation; grafting; hydrogels; review; structure;
D O I
10.1016/s0939-6411(03)00160-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this review was to provide a detailed overview of physical chitosan hydrogels and related networks formed by aggregation or complexation. which are intended for biomedical applications. The structural basis of these systems is discussed with particular emphasis on the network-forming interactions, the principles governing their formation and their physicochemical properties. An earlier review discussing crosslinked chitosan hydrogels highlighted the potential negative influence on biocompatibility of covalent crosslinkers and emphasised the need for alternative hydrogel systems. A possible means to avoid the use of covalent crosslinkers is to prepare physical chitosan hydrogels by direct interactions between polymeric chains, i.e. by complexation, e.g. polyelectrolyte complexes (PEC) and chitosan/poly (vinyl alcohol) (PVA) complexes, or by aggregation, e.g. grafted chitosan hydrogels. PEC exhibit a higher swelling sensitivity towards pH changes compared to covalently crosslinked chitosan hydrogels, which extends their potential application. Certain complexed polymers, Such as glycosaminoglycans, can exhibit interesting intrinsic properties. Since PEC are formed by non-permanent networks, dissolution can occur. Chitosan/PVA complexes represent an interesting alternative for preparing biocompatible drug delivery systems if pH-controlled release is Not required. Grafted chitosan hydrogels are more complex to prepare and do not always improve biocompatibility compared to covalently crosslinked hydrogels, but can enhance certain intrinsic properties of chitosan such as bacteriostatic and wound-healing activity. (C) 2003 Published by Elsevier B.V.
引用
收藏
页码:35 / 52
页数:18
相关论文
共 188 条
[1]   Release of triamcinolone acetonide from mucoadhesive polymer composed of chitosan and poly(acrylic acid) in vitro [J].
Ahn, JS ;
Choi, HK ;
Chun, MK ;
Ryu, JM ;
Jung, JH ;
Kim, YU ;
Cho, CS .
BIOMATERIALS, 2002, 23 (06) :1411-1416
[2]   STUDIES ON CHITOSAN .3. EVIDENCE FOR THE PRESENCE OF RANDOM AND BLOCK COPOLYMER STRUCTURES IN PARTIALLY N-ACETYLATED CHITOSANS [J].
AIBA, S .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1991, 13 (01) :40-44
[3]  
Amaike M, 1998, MACROMOL RAPID COMM, V19, P287, DOI 10.1002/(SICI)1521-3927(19980601)19:6<287::AID-MARC287>3.0.CO
[4]  
2-X
[5]   Surface modification of chitosan membranes by complexation-interpenetration of anionic polysaccharides for improved blood compatibility in hemodialysis [J].
Amiji, MM .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1996, 8 (04) :281-298
[6]  
[Anonymous], CHITIN ENZYMOLOGY
[7]   STUDY OF THE STOICHIOMETRIC POLYELECTROLYTE COMPLEX BETWEEN CHITOSAN AND CARBOXYMETHYL CELLULOSE [J].
ARGUELLESMONAL, W ;
GARCIGA, M ;
PENICHECOVAS, C .
POLYMER BULLETIN, 1990, 23 (03) :307-313
[8]   SWELLING OF MEMBRANES FROM THE POLYELECTROLYTE COMPLEX BETWEEN CHITOSAN AND CARBOXYMETHYL CELLULOSE [J].
ARGUELLESMONAL, W ;
HECHAVARRIA, OL ;
RODRIGUEZ, L ;
PENICHE, C .
POLYMER BULLETIN, 1993, 31 (04) :471-478
[9]  
BERGER J, UNPUB EUR J PHARM BI
[10]   Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N [J].
BernkopSchnurch, A ;
Paikl, C ;
Valenta, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (07) :917-922